Objective: To compare the clinical efficacy

toxic side effects and immune function between modified Sijunzi decoction combined with tegafur gimeracil oteracil potassium capsule and pure tegafur gimeracil oteracil potassium capsule in treating late gastric cancer. Method: Fourty cases of late gastric cancer patients were randomly divided into the observation group (modified Sijunzi decoction combined with tegafur gimeracil oteracil potassium capsule) and the control group (pure tegafur gimeracil oteracil potassium capsule) and the differences in the recent therapeutical effect

immune function

adverse reactions and the quality of life were observed. Result: .Comparisons of the effect

quality of life

and immune function of two groups showed the observation group was superior to the control group(P<0.05);and toxic effects of the the observation group were significantly lower than these in the control group(P<0.05). Conclusion: Modified Sijunzi decoction combined with tegafur gimeracil oteracil potassium capsule for the treatment of late gastric cancer can enhance the curative effect

reduce toxic effects

improve the immune function of patients

and increase the quality of life of the patients.